Emerging Treatment Options for the Myelodysplastic Syndromes

Noelle Frey, MD, a hematologist-oncologist at Penn Medicine and the Abramson Cancer Center, presents a summary of approaches to the myelodysplastic syndromes with a focus upon improved prognosis and the application of novel drug therapies.

 

 

Related Links


Published

August 14, 2014

Created by

Penn Physician VideoLink